Suzuken Co Ltd
TSE:9987
Operating Margin
Suzuken Co Ltd
Operating Margin represents how efficiently a company is able to generate profit through its core operations.
Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.
Operating Margin Across Competitors
| Country | Company | Market Cap |
Operating Margin |
||
|---|---|---|---|---|---|
| JP |
|
Suzuken Co Ltd
TSE:9987
|
357.2B JPY |
2%
|
|
| US |
|
Mckesson Corp
NYSE:MCK
|
81.5B USD |
1%
|
|
| US |
|
Cencora Inc
NYSE:COR
|
49.8B USD |
1%
|
|
| US |
A
|
Amerisourcebergen Corp
LSE:0HF3
|
49.6B USD |
1%
|
|
| US |
|
Cardinal Health Inc
NYSE:CAH
|
30.8B USD |
1%
|
|
| AU |
|
Sigma Healthcare Ltd
ASX:SIG
|
33.2B AUD |
0%
|
|
| US |
|
Henry Schein Inc
NASDAQ:HSIC
|
8.7B USD |
6%
|
|
| CN |
|
Huadong Medicine Co Ltd
SZSE:000963
|
62.2B CNY |
10%
|
|
| KR |
|
Celltrion Healthcare Co Ltd
KOSDAQ:091990
|
12.2T KRW |
9%
|
|
| AU |
E
|
EBOS Group Ltd
OTC:EBOSY
|
8.2B USD |
4%
|
|
| CN |
|
Sinopharm Group Co Ltd
HKEX:1099
|
60.9B HKD |
4%
|
Suzuken Co Ltd
Glance View
In the intricate tapestry of Japan’s healthcare landscape, Suzuken Co., Ltd. emerges as a key player, deftly weaving its capabilities in the pharmaceutical distribution sector. Founded in 1932, Suzuken has evolved from humble beginnings into a giant distributor, serving as a crucial conduit between pharmaceutical manufacturers and healthcare institutions. The company's core operation revolves around the efficient distribution of pharmaceuticals, medical devices, and related healthcare products. From temperature-sensitive vaccines to essential life-saving medicines, Suzuken ensures that these critical items reach hospitals, clinics, and pharmacies across Japan promptly and safely. This role not only underscores the importance of logistics in healthcare but also highlights Suzuken's commitment to ensuring that patients’ needs are met with reliability and precision. Moreover, Suzuken’s revenue engine is powered by its extensive network of subsidiaries and a streamlined supply chain, enabling it to fulfill diverse customer demands while optimizing costs. The company strategically balances its portfolio by engaging in the manufacture of certain generic drugs and offering medical information services, thus enhancing its value proposition. This diversification aids in stabilizing revenue streams amidst the volatility of drug pricing and policy changes in the healthcare sector. By maintaining strong partnerships with numerous pharmaceutical firms and leveraging technological advancements in logistics, Suzuken bolsters its position as a stalwart in the industry. In doing so, it creates a ripple effect that supports the broader ecosystem—ensuring timely healthcare delivery to Japan's aging population and contributing significantly to the national goal of a resilient healthcare infrastructure.
See Also
Operating Margin represents how efficiently a company is able to generate profit through its core operations.
Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.
Based on Suzuken Co Ltd's most recent financial statements, the company has Operating Margin of 1.6%.
You don't have any saved screeners yet